Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak Extends to Second Straight Session
- September 15, 2026
- Posted by: Kunal Singla
- Category: News
Alkem Laboratories Ltd. has now set a fresh 52-week low for its second straight session, with the stock moving to Rs 4,900 from a recent one-year trough of Rs 4,884 and registering a cumulative decline of 1.9% across the streak.For readers tracking the Alkem Laboratories Ltd. 52 Week Low Streak, the key point is that the stock has stayed under pressure across more than one session.
With a market capitalisation of Rs 59,722.72 crore, Alkem Laboratories Ltd. remains a large listed healthcare company, but the repeated low pattern carries a different meaning from a one-day break below the prior trough. A single-day dip can be a temporary move; a Alkem Laboratories Ltd. 52 Week Low Streak shows that the one-year low has been reset again and again over consecutive sessions, which is why the cumulative move deserves more attention than the latest traded price alone.
Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,900 |
| Previous Close | Rs 4,965.15 |
| Today's Move | Rs -65.15 (-1.31%) |
| Open | Rs 4,996.9 |
| High | Rs 4,996.9 |
| Low | Rs 4,884 |
| Market Capitalisation | Rs 59,722.72 crore |
Alkem Laboratories Ltd. (ALKEM) traded at Rs 4,900 versus the previous close of Rs 4,965.15, a fall of 1.31%. The stock opened at Rs 4,996.9, reached a high of Rs 4,996.9, touched a low of Rs 4,884.
At 9:22 AM IST, Alkem Laboratories Ltd. was trading at Rs 4,900, which was Rs 65.15 lower than the previous close of Rs 4,965.15 and down 1.31% for the session. The stock opened at Rs 4,996.90, matched the day’s high at Rs 4,996.90 and slipped to a low of Rs 4,884, which was also the fresh 52-week low. In other words, the latest traded price was sitting close to the session floor after failing to hold above the opening level.
The intraday range shows that the market kept the stock near the lower end of the band through the morning trade. For the Alkem Laboratories Ltd. 52 Week Low Streak, that matters because the repeated move below the prior trough is now part of a broader pattern rather than a one-off breach. The market capitalisation of Rs 59,722.72 crore places the company among the more valuable names in its segment, but the current price action still reflects continued weakness. The Alkem Laboratories Ltd. 52 Week Low Streak therefore remains the central story, not just the day’s percentage fall.
What the Repeated 52-Week Lows Show for Alkem Laboratories Ltd.
The Alkem Laboratories Ltd. 52 Week Low Streak shows that the stock has now renewed its one-year trough in back-to-back sessions, with the latest low at Rs 4,884 and the latest traded price at Rs 4,900. Across the streak, the cumulative decline is 1.9%, which is the clearest way to understand how far the stock has moved over the full run. This is not just a story about today’s decline; it is a story about repeated resets of the 52-week low.
The most important comparison is the new low versus the prior low.For readers following the Alkem Laboratories Ltd. 52 Week Low Streak, that distinction matters: the price has not merely touched support once, it has continued to discover lower levels on subsequent sessions.
Latest News Around Alkem Laboratories Ltd. (ALKEM)
Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 59,722.72 crore |
| P/E Ratio | 27.52x |
| P/B Ratio | 4.15x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 1.07% |
Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P/E 27.52x, P/B 4.15x, ROE 18.29%, ROCE 21.28%. Taken on their own, these numbers offer context rather than a trading signal.
Alkem Laboratories Ltd. has a market capitalisation of Rs 59,722.72 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 27.52x, P/B at 4.15x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 180.45, book value per share of Rs 1,196.51, dividend yield of 1.07%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.49x, median ROE of 11.23%, median ROCE of 13.24%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 27.52x |
| Benchmark Median P/E | 31.49x |
| Benchmark Average P/E | 45.5x |
| Benchmark P/E Range | 3.4x to 616.23x |
| Company P/B Ratio | 4.15x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.24% |
| Company Market Capitalisation | Rs 59,722.72 crore |
| Benchmark Median Market Cap | Rs 768.75 crore |
Alkem Laboratories Ltd. (ALKEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 27.52x, which is below the benchmark median of 31.49x, a difference of -12.61%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.23%, a difference of +62.87%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.24%, a difference of +60.73%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Ltd. | GLENMARK | 62,339.2 | 34.61 | 5.68 | 14.1 | 20.35 |
| Biocon Ltd. | BIOCON | 55,491.09 | 109.73 | 1.6 | 1.35 | 3.26 |
| Abbott India Ltd. | ABBOTINDIA | 54,909.79 | 33.88 | 10.57 | 34.67 | 46.72 |
| Gland Pharma Ltd. | GLAND | 49,952.91 | 42.75 | 4.54 | 10.56 | 14.96 |
| Ipca Laboratories Ltd. | IPCALAB | 46,049.85 | 37.13 | 5.73 | 15.88 | 19.41 |
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 27.52x compared with the displayed peer median of 37.13x. The comparison is relative and should not be read as a recommendation. Its ROE of 18.29% compares with a peer median of 14.1% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.41%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 59,722.72 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.
Why Investors Are Watching Alkem Laboratories Ltd.
- The Alkem Laboratories Ltd. 52 Week Low Streak shows that the stock has now reset its yearly low in consecutive sessions.
- The cumulative decline across the streak is 1.9%, which is more informative than the latest session move alone.
- The latest low of Rs 4,884 is lower than the previous one-year trough, confirming that the pattern has extended.
- The company’s P/E, P/B, ROE and ROCE now need to be viewed in the context of the lower share price.
About Alkem Laboratories Ltd.
Alkem Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For the Alkem Laboratories Ltd. 52 Week Low Streak, the important business context is that this is a large company with a market capitalisation of Rs 59,722.72 crore, a P/E of 27.52 and a P/B of 4.15. Those figures help frame the decline, but they do not explain it on their own.
The company’s reported ROE of 18.29%, ROCE of 21.28%, EPS of Rs 180.45 and book value of Rs 1,196.51 give readers a financial context for the stock while it remains in a repeated one-year-low pattern. In the Alkem Laboratories Ltd. 52 Week Low Streak, the business backdrop is relevant because it shows how the valuation and return ratios stand even as the share price keeps moving to fresh lows.
Track Alkem Laboratories Ltd. Share Price on Univest
Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
The Alkem Laboratories Ltd. 52 Week Low Streak can be followed on the company’s share-price page for the latest traded price, the day’s range and updated valuation metrics. Readers tracking repeated lows should focus on whether the streak continues, whether the cumulative decline widens further and whether any fresh company-specific development changes the pattern.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What does the Alkem Laboratories Ltd. 52 Week Low Streak mean?
Ans. It means Alkem Laboratories Ltd. has set a fresh 52-week low in consecutive sessions. The pattern confirms repeated downside, but by itself it does not prove a specific company-level reason for the move.
How many sessions has Alkem Laboratories Ltd. set a fresh 52-week low?
Ans. The stock has now set a fresh 52-week low for its second straight session. That makes this an extended streak rather than a single-day breakdown. The stock moved -1.31% during the session.
What is the latest 52-week low for Alkem Laboratories Ltd.?
Ans. The latest 52-week low reported for the streak is Rs 4,884. The latest traded price at the article time was Rs 4,900, which remained close to that trough. The stock moved -1.31% during the session.
How does the current low compare with the previous low?
Ans.That confirms the repeated-low pattern has continued rather than paused. Comparable listed companies include Glenmark Pharmaceuticals Ltd., Biocon Ltd., Abbott India Ltd.
How does Alkem Laboratories Ltd. look on valuation after the streak?
Ans. The stock is trading at a P/E of 27.52 and a P/B of 4.15. After the streak, the lower share price has reduced the multiple, while earnings and book value have not changed across the move.
How does Alkem Laboratories Ltd. compare with sector benchmarks?
Ans. Its P/E is below the industry median, while its P/B is above the industry median. ROE and ROCE are also above the industry medians shown, which gives the decline an important relative-value context.
What should investors monitor next in the Alkem Laboratories Ltd. 52 Week Low Streak?
Ans. Investors may watch whether the stock keeps printing fresh lows, whether the cumulative decline deepens further and whether any new company development changes the pattern. The repeated low itself remains the main signal for now.